Skip to main content

Organigram Global Inc.

OGI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001620737

No open-market purchases or sales by Organigram Global Inc. insiders were filed in the last 90 days; 69 institutions reported holding it in 13F filings for Q2 2026, worth $7.87M in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Organigram Global Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of OGI: Q2 2023 compared with Q3 2023
MeasureQ2 2023Of which not filed for Q3 2023Q3 2023Change
Holders86173−12
SharesConverted for a 1-for-4 split3.93M39.754.26M+331.8K (+8.4%)
Value$6.05M$62$5.86M−$188.2K (−3.1%)

1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (14)

Institutions that held Organigram Global Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to OGI in Q3 2023
InstitutionSharesValue% of portfolio
Vontobel Holding Ltd.172,824$229.0K0.00%
Penserra Capital Management LLC169,800$224.0K0.00%
Old Mission Capital LLC97,416$128.6K0.00%
HighTower Advisors, LLC11,856$15.0K0.00%
Capital Advisors Inc10,157$13.4K0.00%
Simplex Trading, LLC8,427$11.0K0.00%
Johnson Midwest Financial, LLC463$6110.00%
Toronto Dominion Bank75$990.00%
Wells Fargo & Company50$660.00%
Gables Capital Management Inc.50$660.00%
Qube Research & Technologies Ltd20$260.00%
GPS Wealth Strategies Group, LLC6$80.00%
Nemes Rush Group LLC2$30.00%
NBC Securities, Inc.500$00.00%

Sold out (26)

Institutions that held Organigram Global Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Not filed for Q3 2023 yet (1)

Institutions that held Organigram Global Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding OGI in Q2 2023 that haven't filed for Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
Coastal Capital Group, Inc.159$62